Literature DB >> 1419811

Immunophenotyping of fetal haemopoietic cells permissive for human parvovirus B19 replication in vitro.

A L Morey1, K A Fleming.   

Abstract

Human parvovirus B19 is known to inhibit erythroid colony formation in vitro, but the precise stage of differentiation at which erythroid precursors become capable of supporting viral replication has not been accurately determined. In order to address this issue, haemopoietic cells derived from first trimester fetal liver were cultured in medium containing B19 antigen-positive serum. Infected cells were phenotyped by combining immunohistology for cell-type specific antigens with non-isotopic in situ hybridization for B19 nucleic acid. Strong nuclear hybridization signal was detected as early as 8 h after infection in erythroid precursors labelling with antibodies to glycophorin A, glycophorin C, CD43, CD36 and HLA-ABC (pronormoblast or normoblast phenotype). Giant erythroid precursors labelling with the same five antibodies were a pathognomonic feature of infected cultures, but contained relatively little B19 nucleic acid. Hybridization signal was not detected in progenitor cells of more primitive erythroid phenotype or in nuclei of cells of other lineages, though B19 DNA was occasionally localized within the cytoplasm of macrophages. Double-labelling with antibody Ki-67 confirmed that proliferating cells were targets for B19 infection. Co-detection of cell-type specific antigens and viral nucleic acid is a powerful tool for investigating host cell specificity, and suggests that proliferating late erythroid precursors are the only haemopoietic cells fully permissive for B19 infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1419811     DOI: 10.1111/j.1365-2141.1992.tb06422.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  22 in total

1.  Immunohistochemical identification of erythroid precursors in paraffin embedded bone marrow sections: spectrin is a superior marker to glycophorin.

Authors:  Y Sadahira; A Kanzaki; H Wada; Y Yawata
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

2.  Human B19 erythrovirus in vitro replication: what's new?

Authors:  Sylvie Pillet; Serge Fichelson; Frédéric Morinet; Neal S Young; Ning Zhi; Susan Wong
Journal:  J Virol       Date:  2008-09       Impact factor: 5.103

3.  Expression of p53 and Ki-67 antigen in bone marrow giant proerythroblasts associated with human parvovirus B19 infection.

Authors:  Y Sadahira; T Sugihara; Y Yawata
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

4.  Combined immunocytochemistry and non-isotopic in situ hybridization for the ultrastructural investigation of human parvovirus B19 infection.

Authors:  A L Morey; D J Ferguson; K A Fleming
Journal:  Histochem J       Date:  1995-01

5.  Intracellular localization of parvovirus B19 nucleic acid at the ultrastructural level by in situ hybridization with digoxigenin-labelled probes.

Authors:  A L Morey; D J Ferguson; K O Leslie; D J Taatjes; K A Fleming
Journal:  Histochem J       Date:  1993-06

6.  Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.

Authors:  Wei Zou; Zekun Wang; Min Xiong; Aaron Yun Chen; Peng Xu; Safder S Ganaie; Yomna Badawi; Steve Kleiboeker; Hiroshi Nishimune; Shui Qing Ye; Jianming Qiu
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

7.  Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.

Authors:  Yong Luo; Steve Kleiboeker; Xuefeng Deng; Jianming Qiu
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

Review 8.  Parvovirus B19 infection.

Authors:  J R Kerr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

9.  Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication.

Authors:  Susan Wong; Ning Zhi; Claudia Filippone; Keyvan Keyvanfar; Sachiko Kajigaya; Kevin E Brown; Neal S Young
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

10.  A case of pure red cell aplasia: follow-up on different immunosuppressive regimens.

Authors:  M Baldus; M Möller; H Walter; H Brass; W Queisser
Journal:  Clin Investig       Date:  1994-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.